146 related articles for article (PubMed ID: 1279363)
1. Prevalence of hepatitis C virus antibodies in Sydney blood donors.
Archer GT; Buring ML; Clark B; Ismay SL; Kenrick KG; Purusothaman K; Kaldor JM; Bolton WV; Wylie BR
Med J Aust; 1992 Aug; 157(4):225-7. PubMed ID: 1279363
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus prevalence and incidence estimates among Chinese blood donors.
Fu P; Lv Y; Zhang H; Liu C; Wen X; Ma H; He T; Ke L; Wu B; Liu J; He M; Liao D; Wang J; Ness P; Liu Y; Shan H;
Transfusion; 2019 Sep; 59(9):2913-2921. PubMed ID: 31271469
[TBL] [Abstract][Full Text] [Related]
4. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
6. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
7. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
8. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro.
Vanderborght BO; Reis AM; Rouzere CD; da Silva RS; Yoshida CF; Franco LG; Maertens G; Van Heuverswijn H; Moreira Pereira J
Vox Sang; 1993; 65(2):122-5. PubMed ID: 7692672
[TBL] [Abstract][Full Text] [Related]
10. A study of anti-hepatitis C positive blood donors: the first year of screening.
MacLennan S; Moore MC; Hewitt PE; Nicholas S; Barbara JA
Transfus Med; 1994 Jun; 4(2):125-33. PubMed ID: 7522834
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
12. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
13. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C virus antibody in the serum of blood donors].
Barna TK; Ozsvár Z; Szendrényi V; Gál G
Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
[TBL] [Abstract][Full Text] [Related]
15. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan.
Tsai SJ; Chen CJ; Hsieh YS; Yang CS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):61-70. PubMed ID: 1657546
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors.
McCaughan GW; McGuinness PH; Bishop GA; Painter DM; Lien AS; Tulloch R; Wylie BR; Archer GT
Med J Aust; 1992 Aug; 157(4):231-3. PubMed ID: 1279365
[TBL] [Abstract][Full Text] [Related]
19. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
20. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
